Uniting Europe & Asia to Realise CAR-TCR Based Therapies for Patients
This year’s meeting is more comprehensive than ever, kicking off with two strategic bootcamps dedicated to strengthening your clinical development strategy.
Regulatory Bootcamp Day
Gain practical regulatory insights from leading global experts to accelerate approval timelines and streamline global development with AstraZeneca, Cabaletta Bio, Heidelberg University Hospital and more
Investment & Partnerships Day
Gain actionable insights to strengthen partnerships, secure funding, and accelerate early human data generation in a challenging financial climate with the likes of IASO Biotherapeutics, Eso Bioech, AstraZeneca, Hospital Clinic Barcelona
Main Conference Days - What to Expect?
The science behind CAR and TCR therapies is at the heart of this summit as we enter the main conference days, where you will:
Clinical Data
Hear the latest clinical data, discuss designing clinical trials with patient access in mind, and dive into cutting edge in-vivo data
R&D Track
Explore innovations in science in the R&D Track to including novel targets, next gen receptor constructs, armouring, and more
Manufacturing Track
Overcome barriers to realising scale and access in the Manufacturing Track by learning from those investing in automation, point of care manufacturing, and strategies to reduce cost of goods
Key Takeaways
Next-Gen Therapies
Understand next-generation CAR and TCR therapies expanding beyond traditional T-cells.
Improve Manufacturing Scalability
Explore in-vivo engineering and advanced delivery technologies to improve manufacturing scalability.
Real-World Data
Analyse the latest clinical and real-world data across novel CAR-T and allogeneic platforms.
Expand Patient Access
Learn strategies to expand patient access through scalable and lean manufacturing approaches.
Regulatory Pathways
Navigate global regulatory pathways, investment opportunities, and partnership strategies for accelerated development.
Divide & Conquer
R&D
Advancing Next-Generation TCR Therapies Targeting ROPN1 to Address Triple-Negative Breast Cancer
- Introduce the rationale for targeting ROPN1 as a novel and tumour-specific antigen in TNBC
- Highlight how next-generation TCR engineering enhances specificity and potency against hard-to-treat solid tumours
- Discuss translational and clinical development plans to demonstrate safety, efficacy, and durable responses in TNBC patients
Rachel Abott, Chief Executive Officer, Pan Cancer T
CARKey: a CAR-T Platform to Mitigate Tumour Antigen Heterogeneity & On-Target-Off Tumour Toxicity
- Development of CARKey platform technology with multi receptor targeting
- Identification of combinatorial target proteins through bioinformatic analysis
- Rapid and strategic development of clinical candidate
John Bridgeman, Chief Scientific Officer, Immunokey
Manufacturing
Driving Efficiency & Unlocking Scalability for PRAME Cell Therapy Manufacturing
- Anzu-cel is TCR T-cell therapy directed against PRAME, a target expressed in more than 50 cancers
- Scaling out efficiently: horizontal expansion to increase speed and throughput
- Preparing for commercial manufacturing through operational excellence
Ali Mohamed, Senior Vice President, CMC, Immatics
Exploring Automation to Scale Out Autologous CAR-T Manufacturing
- Examine how automation enables scalable, parallelised production of autologous CAR-T therapies without compromising quality
- Discuss how streamlined, modular manufacturing platforms can lower costs and accelerate patient access
Sarah Yuan, Chief Technical Officer, Cabaletta Bio
Explore the Full Event Guide
- Brand new companies including EsoBiotec, Pan Cancer T, Quell Therapeutics and Immunokey
- Key sessions covering R&D all the way to commercialisation to understand the advances made across the full value chain
- Data from leading in-vivo, CAR-NK, CAR-T, TCR-T, and CAR-Macrophage developers
- Strategic insights to streamline regulatory approvals and discover opportunities for funding
Attending Companies Include
![CB-CDx-0690-min-scaled11[1]](https://cartcr-europe.com/wp-content/uploads/sites/229/2024/06/CB-CDx-0690-min-scaled111.jpg "CB-CDx-0690-min-scaled11[1]")
Explore the Programme
From breakthrough clinical data to cutting-edge manufacturing technology, pick and choose your own journey through the CAR-TCR Summit
![CB-CDx-0330-min-scaled11[1]](https://cartcr-europe.com/wp-content/uploads/sites/229/2024/06/CB-CDx-0330-min-scaled111.jpg "CB-CDx-0330-min-scaled11[1]")
Establish Partnerships
Whether you’re looking for a pharma, academic, biotech or service provider partner this is the place to be
![Join-Biopharma-Experts11[1]](https://cartcr-europe.com/wp-content/uploads/sites/229/2024/06/Join-Biopharma-Experts111.png "Join-Biopharma-Experts11[1]")
Shape the Future of CAR-TCR
Be part of the hottest conversations with like-minded attendees from Europe, Asia and beyond